Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,920 | -72,559 | -42,203 | -68,889 | -49,670 |
| Depreciation Amortization | 2,823 | 1,051 | 259 | -3,470 | -2,375 |
| Accounts receivable | -17,585 | -7,813 | -2,857 | -1,465 | -2,668 |
| Other Working Capital | -40,281 | -22,272 | -7,415 | 93,266 | 117,667 |
| Other Operating Activity | 31,377 | 16,881 | 7,097 | 17,108 | 13,757 |
| Operating Cash Flow | $-123,586 | $-84,712 | $-45,119 | $36,550 | $76,711 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,243 | -17,422 | -8,822 | -59,394 | -220,692 |
| PPE Investments | -13,894 | -9,760 | -5,977 | -43,065 | -15,028 |
| Net Acquisitions | N/A | N/A | N/A | -75,647 | N/A |
| Purchase Of Investment | -262 | N/A | N/A | N/A | -5,221 |
| Investing Cash Flow | $-43,399 | $-27,182 | $-14,799 | $-178,106 | $-240,941 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 141,198 | 140,402 | 481 | 231,963 | 230,226 |
| Other Financing Activity | -388 | -296 | -265 | -254 | -83 |
| Financing Cash Flow | $140,810 | $140,106 | $216 | $231,709 | $230,143 |
| Exchange Rate Effect | 48 | 592 | 252 | 439 | N/A |
| Beginning Cash Position | 143,918 | 143,918 | 143,918 | 53,326 | 53,326 |
| End Cash Position | 117,791 | 172,722 | 84,468 | 143,918 | 119,239 |
| Net Cash Flow | $-26,127 | $28,804 | $-59,450 | $90,592 | $65,913 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,586 | -84,712 | -45,119 | 36,550 | 76,711 |
| Capital Expenditure | -13,894 | -9,760 | -5,977 | -43,065 | -15,028 |
| Free Cash Flow | -137,480 | -94,472 | -51,096 | -6,515 | 61,683 |